These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30876455)

  • 1. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.
    Lehman NL; Hattab EM; Mobley BC; Usubalieva A; Schniederjan MJ; McLendon RE; Paulus W; Rushing EJ; Georgescu MM; Couce M; Dulai MS; Cohen ML; Pierson CR; Raisanen JM; Martin SE; Lehman TD; Lipp ES; Bonnin JM; Al-Abbadi MA; Kenworthy K; Zhao K; Mohamed N; Zhang G; Zhao W
    Neuro Oncol; 2017 Jan; 19(1):31-42. PubMed ID: 27416954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement.
    Hirose T; Nobusawa S; Sugiyama K; Amatya VJ; Fujimoto N; Sasaki A; Mikami Y; Kakita A; Tanaka S; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):684-694. PubMed ID: 28990708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
    Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
    Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
    Lehman NL
    J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.
    Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D
    Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MN1 rearrangement in astroblastoma: study of eight cases and review of literature.
    Mhatre R; Sugur HS; Nandeesh BN; Chickabasaviah Y; Saini J; Santosh V
    Brain Tumor Pathol; 2019 Jul; 36(3):112-120. PubMed ID: 31111274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of morphological findings in pediatric central nervous system MN1-fusion-positive neuroepithelial tumors.
    Lubieniecki F; Vazquez V; Lamas GS; Camarero S; Nuñez FJ; Baroni L; Schüller U; Alderete D
    Childs Nerv Syst; 2023 Feb; 39(2):379-386. PubMed ID: 36534132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600E-mutated central nervous system tumor with divergent morphological feature - Anaplastic pleomorphic xanthoastrocytoma-like and astroblastoma-like.
    Purkait S; Bansal S; Malgulwar PB
    Neuropathology; 2019 Feb; 39(1):64-67. PubMed ID: 30557911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration.
    Baroni LV; Rugilo C; Lubieniecki F; Sampor C; Freytes C; Nobre L; Hansford JR; Malalasekera VS; Zapotocky M; Dodgshun A; Martinez OC; La Madrid AM; Lavarino C; Suñol M; Rutkowski S; Schuller U; Bouffet E; Ramaswamy V; Alderete D
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28627. PubMed ID: 32959992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pediatric cerebral tumor with MN1 alteration and pathological features mimicking carcinoma metastasis: may the terminology "high grade neuroepithelial tumor with MN1 alteration" still be relevant?
    Sari R; Altinoz MA; Ozyar E; Danyeli AE; Elmaci I
    Childs Nerv Syst; 2021 Oct; 37(10):2967-2974. PubMed ID: 34269865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
    Burel-Vandenbos F; Pierron G; Thomas C; Reynaud S; Gregoire V; Duhil de Benaze G; Croze S; Chivoret N; Honavar M; Figarella-Branger D; Maurage CA; Pedeutour F; Hasselblatt M; Godfraind C
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):506-509. PubMed ID: 32397004
    [No Abstract]   [Full Text] [Related]  

  • 18. Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases.
    Chen W; Soon YY; Pratiseyo PD; Sutanto R; Hendriansyah L; Kuick CH; Chang KTE; Tan CL
    Brain Tumor Pathol; 2020 Oct; 37(4):145-153. PubMed ID: 32601775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
    Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
    Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
    Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
    Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.